Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-30

FDA Approved: RAMELTEON — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

The FDA approved a supplemental application for ramelteon submitted by Dr. Reddy's Laboratories (ANDA 091693) related to the ramelteon product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)